You are here: Industry Insights > BioNTech

News List

BioNTech says vaccine likely to be effective against Indian variant expresspharma
May 24, 2021
BioNTech SE said yesterday that the COVID-19 vaccine it developed with Pfizer should be roughly as effective against the new coronavirus variant first detected in India as it has been shown to be against the South African variant.
Pfizer, BioNTech to Supply Additional COVID-19 Vax Doses to Turkey contractpharma
May 21, 2021
Pfizer and BioNTech Europe GmbH have entered an agreement with Turkey’s Ministry of Health to supply 60 million additional doses of the companies’ COVID-19 vaccine, with an option for an additional 30 million doses.
Pfizer, BioNTech to Supply EU with Additional COMIRNATY Doses contractpharma
May 21, 2021
Pfizer and BioNTech SE entered a new agreement with the European Commission (EC) to supply 900 million doses of COMIRNATY, the companies’ COVID-19 vaccine, to the EU, with an option for the EC to request up to an additional 900 million doses.
Pfizer, BioNTech get US FDA nod for emergency use of COVID-19 vaccine in adolescents expresspharma
May 12, 2021
Pfizer and BioNTech SE announced that the US Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for their COVID-19 vaccine to include individuals 12 to 15 years of age.
Pfizer and BioNTech to provide COVID-19 vaccine doses for olympic athletes at the 2020 Tokyo Games worldpharmanews
May 11, 2021
Pfizer Inc. and BioNTech SE announced the signing of a Memorandum of Understanding (MoU) with the International Olympic Committee (IOC) to donate doses of the companies' COVID-19 Vaccine to help vaccinate athletes, and their delegations, participating ...
BioNTech to Establish Regional HQ and Mfg. Facility in Singapore contractpharma
May 11, 2021
New manufacturing site will support global supply of mRNA-based vaccines and therapeutics.
Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of their COVID-19 Vaccine americanpharmaceuticalreview
May 08, 2021
Pfizer Inc. and BioNTech SE have announced the initiation of a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for approval of their mRNA vaccine to prevent COVID-19 in individuals 16 years of age and older.
Health Canada approves Pfizer and BioNTech’s Covid-19 vaccine for adolescents pharmaceutical-technology
May 07, 2021
With Health Canada authorisation, the Pfizer and BioNTech vaccine became the first-of-its-kind indicated for this age group to receive approval in the country.
UK buys another 60 million doses of Pfizer/BioNTech vaccine pharmatimes
May 06, 2021
The UK government has secured an extra 60 million doses of Pfizer/BioNTech’s COVID-19 vaccine, in a bid to strengthen plans for the autumn COVID-19 vaccination programme.
Pfizer, BioNTech seek CMA expansion for Covid-19 vaccine in EU pharmaceutical-technology
May 06, 2021
Pfizer and BioNTech have submitted a request to the European Medicines Agency (EMA) to expand Conditional Marketing Authorization (CMA) of their Covid-19 vaccine, COMIRNATY (BNT162b2), in the European Union (EU) for use in adolescents aged 12 to 15 years.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page